Found in translation: turning mouse mammary biology into clinical benefit
Dr Matt Smalley,Cancer Stem Cell Research Institute, Cardiff University.
Dr. Matt Smalley is Deputy Director of the European Cancer Stem Cell Research Institute, Cardiff University. Prior to this, Matt's group was based at the Breakthrough Breast Cancer Research Centre at the ICR, London.
His research group is trying to understand how the combination of different tumour-initiating genetic lesions occurring in different normal stem and progenitor cells in the breast drives breast cancer heterogeneity, predominately through the use of genetically engineered mice. His lab is also trying to understand how the biological processes occurring in normal stem cells can be re-activated in tumours to drive de novo production of tumour cells with stem cell-like properties.
Matt has published some excellent seminal (Cell Stem Cell, Dev Cell and Development) and his talk will be great.
If anyone would like to chat to Matt throughout the day on the Tuesday, then please let me know.
See you there!